JP2025504474A5 - - Google Patents

Info

Publication number
JP2025504474A5
JP2025504474A5 JP2024543108A JP2024543108A JP2025504474A5 JP 2025504474 A5 JP2025504474 A5 JP 2025504474A5 JP 2024543108 A JP2024543108 A JP 2024543108A JP 2024543108 A JP2024543108 A JP 2024543108A JP 2025504474 A5 JP2025504474 A5 JP 2025504474A5
Authority
JP
Japan
Prior art keywords
sarna
antisense strand
sense strand
seq
nucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024543108A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025504474A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/072076 external-priority patent/WO2023138502A1/en
Publication of JP2025504474A publication Critical patent/JP2025504474A/ja
Publication of JP2025504474A5 publication Critical patent/JP2025504474A5/ja
Pending legal-status Critical Current

Links

JP2024543108A 2022-01-20 2023-01-13 オリゴヌクレオチド調節因子がユートロフィン発現を活性化する Pending JP2025504474A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2022072958 2022-01-20
CNPCT/CN2022/072958 2022-01-20
PCT/CN2023/072076 WO2023138502A1 (en) 2022-01-20 2023-01-13 Oligonucleotide modulators activating utrophin expression

Publications (2)

Publication Number Publication Date
JP2025504474A JP2025504474A (ja) 2025-02-12
JP2025504474A5 true JP2025504474A5 (cg-RX-API-DMAC7.html) 2026-01-16

Family

ID=87347803

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024543108A Pending JP2025504474A (ja) 2022-01-20 2023-01-13 オリゴヌクレオチド調節因子がユートロフィン発現を活性化する

Country Status (10)

Country Link
US (1) US20250101421A1 (cg-RX-API-DMAC7.html)
EP (1) EP4466359A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025504474A (cg-RX-API-DMAC7.html)
KR (1) KR20250005567A (cg-RX-API-DMAC7.html)
CN (1) CN118829728A (cg-RX-API-DMAC7.html)
AU (1) AU2023209973A1 (cg-RX-API-DMAC7.html)
CA (1) CA3249545A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024008939A (cg-RX-API-DMAC7.html)
TW (1) TW202338088A (cg-RX-API-DMAC7.html)
WO (1) WO2023138502A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025201529A1 (en) * 2024-03-29 2025-10-02 Ractigen Therapeutics Compounds for synthesizing modified small activating rna molecules, modified small activating rna molecules and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8916532B2 (en) * 2008-04-28 2014-12-23 The Trustees Of The University Of Pennsylvania Methods for enhancing utrophin production via inhibition of microRNA
EP2427554B1 (en) * 2009-05-08 2016-11-16 CuRNA, Inc. Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to dmd family
CN104540946A (zh) * 2012-05-16 2015-04-22 Rana医疗有限公司 用于调节utrn表达的组合物和方法
US20170044540A1 (en) * 2014-04-22 2017-02-16 Mina Therapeutics Limited Sarna compositions and methods of use
WO2019183005A1 (en) * 2018-03-19 2019-09-26 The Trustees Of The University Of Pennsylvania 2'f-ana-let7 mediated utrophin upregulation for dmd therapy
WO2021230385A1 (en) * 2020-05-15 2021-11-18 Astellas Pharma Inc. Method for treating muscular dystrophy by targeting utrophin gene

Similar Documents

Publication Publication Date Title
CN113164509B (zh) 用于抑制17β-HSD 13型(HSD17B13)表达的RNAi试剂、其组合物和使用方法
EP3010514B1 (en) Double-stranded antisense nucleic acid with exon-skipping effect
JP7406793B2 (ja) 2テイル自己デリバリー型siRNAおよび関連方法
EP2791335B1 (en) Chimeric double-stranded nucleic acid
JP2023537798A5 (cg-RX-API-DMAC7.html)
JP2023509870A (ja) Hbvの処置のためのhbvを標的とする治療用オリゴヌクレオチドとtlr7アゴニストとの医薬組合せ
ES3001019T3 (es) Inhibidores del MICRO-RNA 22
WO2024175087A1 (en) Oligonucleotide targeting sod1
CN118202049A (zh) 一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
KR20210122731A (ko) 핵산 복합체를 함유하는 피부 투과성 전달체 및 이의 용도
JP2022527529A (ja) Atxn2発現を調節するためのオリゴヌクレオチド
CN121002179A (zh) 寡核苷酸的递送载体及其使用方法
JP2000514095A (ja) 生物学的利用能を向上するためのオリゴヌクレオチド
JP2022520653A (ja) Cyp27a1の発現を阻害するための方法及び組成物
CN118512601A (zh) 双链核酸-半乳糖胺-胆固醇化合物及其应用
WO2024169770A1 (zh) 一种抑制SCN9A基因表达的siRNA、其药物组合物及用途
CN118516348A (zh) 单链核酸或双链核酸及在制备治疗杜氏肌营养不良的药物中的应用
RU2024123023A (ru) Олигонуклеотидные модуляторы, активирующие экспрессию утрофина
AU2003236659B2 (en) Cooperative oligonucleotides
CN120400150B (zh) 一种环状三链形成寡核苷酸及制备方法与在制备肿瘤靶向药物中的应用
JP7216381B2 (ja) Rna作用抑制剤及びその利用
TW202609056A (zh) 靶向sod1的寡核苷酸
SINHA et al. Exploring Backbone Chemistries in Morpholino Gapmers of Oblimersen: It’s Effect on Biophysical Parameters and RNaseH Activity
KR20240110595A (ko) 안정화된 rna 제제
CN119074947A (zh) 一种肝靶向小核酸药物载体、药用组合物及其制备方法和应用